Breast Cancer Foundation NZ
persevERA Breast Cancer
Early Breast Cancer clinical trials for ER+
This study will evaluate the pharmacodynamics, pharmacokinetics, safety, and biologic activity of GDC-9545 in participants with Stage I-III operable ER+, HER2- untreated breast cancer.
This study will evaluate the pharmacodynamics, pharmacokinetics, safety, and biologic activity of GDC-9545 in participants with Stage I-III operable ER+, HER2- untreated breast cancer.
Who is it for?
You may be eligible for this study if you meet the below criteria:
- Ability to comply with the study protocol, in the investigator's judgment.
- Histologically confirmed invasive breast carcinoma, with all of the following characteristics: Primary tumor greater than or equal to (≥)1.5 centimeters (cm) in largest diameter by ultrasound; Stage I-III operable breast cancer; Documentation confirming the absence of distant metastasis (M0) as determined by institutional practice.
- ER-positive tumor and HER2-negative breast cancer as per local laboratory testing.
- Postmenopausal status.
- Breast cancer eligible for primary surgery.
- Submission of a representative tumor tissue specimen.
- Eastern Cooperative Oncology Group (ECOG) Performance Status less than or equal to (≤)1.
- Adequate organ function.
Study details
Participants will receive varying dosages of GDC-9545 once daily, starting on Day 1 up to and including the day of surgery (if allowed per local process) on Day 15.
New Zealand
Australia
Mater Hospital, Brisbane
Princess Alexandra Hospital, Brisbane
Austin Health, Melbourne
Frankston Hospital, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Sunshine Hospital, Melbourne
Fiona Stanley Hospital, Perth
Chris O'Brien Lifehouse, Sydney
If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Similar clinical trials
For Early Breast Cancer
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Interested in a clinical trial?
Subscribe for updates & stay in the loop with new studies.